Gene Y Im, MD

Transplant Hepatology
Gastroenterology, Transplant Surgery
Accepting New Patients
Virtual Visits/Telehealth

On the web

Profile Headshot

Profile Navigation

Overview

Dr. Gene Im is a transplant hepatologist and the Director of ADAPT (Advanced inter-Disciplinary Alcohol liver Program and Treatment), a patient-centered, integrated care and research program for patients with alcohol-associated liver disease (ALD). ADAPT is one of only a few integrated ALD clinics in the country.

Dr. Im is a recognized expert in alcohol-associated liver disease, including alcohol-associated hepatitis and liver transplantation based on his clinical focus and research achievements. He has co-authored several practice-changing articles, including the 2019 ALD Practice Guidance from AASLD, the 2024 MetALD Expert Position Statement, and the first experience of early liver transplantation for alcohol-associated hepatitis in North America.

Currently, he is the Vice-Chair of the AASLD ALD Special Interest Group and serves on the Editorial Board for Liver Transplantation and Clinical Transplantation. Dr. Im is also the founder of ALD-ALLY (Alcohol-associated Liver Disease patients deserve ALcohol LiteracY), an annual conference focused on actionable initiatives for advancing the science and care of patients with ALD and alcohol use disorder.

Dr. Im is an Assistant Professor of Medicine in the Center for Liver Disease and Transplantation and Division of Digestive and Liver Diseases at Columbia University.

Academic Appointments

  • Assistant Professor of Medicine at CUIMC

Administrative Titles

  • Director, Alcohol-associated Liver Disease Program

Gender

  • Male

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

CUIMC/Presbyterian Hospital and Vanderbilt Clinic
622 West 168th Street
New York, NY 10032
Primary
Phone:
212-305-0914
Open location in Google Maps

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Student Health

Affinity Health Plan

  • Essential Plan
  • Medicaid Managed Care

Amida Care

  • Special Needs

Cigna

  • EPO
  • Great West (National)
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross/Blue Shield

  • EPO
  • HMO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199
  • NYP Employee Plan

MagnaCare (National)

  • MagnaCare

Medicare

  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

RiverSpring

  • Special Needs

UnitedHealthcare

  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • Oxford Freedom
  • Oxford HMO
  • Oxford Liberty
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

World Trade Center Health Plan

  • World Trade Center Health Plan

*Before your appointment, please contact the doctor’s office or your insurance provider to verify that your insurance is accepted. This list of insurances can change, and the insurance plans listed may not be accepted at all office locations for this provider.

Credentials & Experience

Education & Training

  • MD, 2005 New York Medical College
  • Residency: 2008 NYU Langone Medical Center & School of Medicine
  • Fellowship: 2012 Mount Sinai Medical Center, New York, NY

Committees, Societies, Councils

  • Vice-Chair, AASLD ALD Special Interest Group

Editorial Boards

  • Board Member, Liver Transplantation
  • Board Member, Clinical Transplantation

Board Certifications

  • Transplant Hepatology
  • Gastroenterology

Honors & Awards

  • Fellow of the AASLD, American Association for the Study of Liver Diseases (AASLD), 2023
  • Presidential Poster of Distinctio, AASLD, The Liver Meeting 2023
  • ELS Mentor, AASLD Emerging Liver Scholar, Jonathan Nahas, 2016
  • Specialty Attending of the Year Teaching Award, Mount Sinai Medical Center, 2014, 2016
  • Young Investigator Travel Award, AASLD, The Liver Meeting, 2013
  • Presidential Poster of Distinction, AASLD, The Liver Meeting, 2013
  • Young Investigator Award, Controversies in Transplantation, Breckenridge, CO, 2013

Research

Selected Publications

  1. Singal AK, Pannerselvam D, Arab JP, Im G, Kuo YF. Delisting From Liver Transplant List for Improvement and Recompensation Among Decompensated Patients at One Year. Am J Gastroenterol. 2024 Dec 23. doi: 10.14309/ajg.0000000000003259. Epub ahead of print. PMID: 39714037. Contribution: data collection, manuscript revision
  2. Arab JP, Díaz LA, Rehm J, Im G, Arrese M, Kamath PS, Lucey MR, Mellinger J, Thiele M, Thursz M, Bataller R, Burton R, Chokshi S, Francque SM, Krag A, Lackner C, Lee BP, Liangpunsakul S, MacClain C, Mandrekar P, Mitchell MC, Morgan MY, Morgan TR, Pose E, Shah VH, Shawcross D, Sheron N, Singal AK, Stefanescu H, Terrault N, Trépo E, Moreno C, Louvet A, Mathurin P. Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease. J Hepatol. 2024 Nov 27:S0168-8278(24)02728-4. Contribution: manuscript writing, manuscript revision
  3. *Rutledge SM, Nathani R, Wyatt BE, Eschbach E, Trivedi P, Kerznerman S, Chu L, Schiano TD, Kim-Schluger L, Florman S, Im GY. Age added to MELD or ACLF predicts survival in patients with alcohol-associated hepatitis declined for liver transplantation. Hepatol Commun. 2024 Aug 19;8(9):e0514.
  4. Dukewich M, Dodge JL, Lucey MR, Rice JP, Shetty K, Jakhete N, Im GY, Weinberg EM, Hsu C, Smith C, Ghobrial RM, Therapondos G, Shoreibah M, Aryan M, Eswaran S, Fix OK, Maddur H, Terrault N, Lee BP. The Survival Benefit of Reabstinence After Harmful Alcohol Use Following Early Liver Transplant for Severe Alcohol-Associated Hepatitis: A Multicenter ACCELERATE Study. Am J Gastroenterol. 2024 Jul 12. Contribution: data collection, manuscript revision
  5. Verma N, Mehtani R, Haiar JM, Pradhan P, Duseja A, Im GY, Singal AK. Clinical criteria accurately diagnose severe but not moderate alcohol-associated hepatitis: A systematic review and meta-analysis. Hepatol Commun. 2024 Mar 18;8(4):e0404. Contribution: study design, manuscript revision
  6. *Winters AC, Nathani RR, Bowman CA, Nahas J, Schiano TD, Florman SS, Im GY. Universal alcohol biomarker monitoring improves drinking detection and accountability during evaluation for liver transplantation. Liver Transpl. 2024 Mar 1;30(3):331-333.
  7. *Nathani RR, Rutledge SM, Villarroel CS, Shapiro R, Florman SS, Tedla FM, Schiano TD, Im GY. Outcomes after kidney transplant alone in patients with cirrhosis-A case-control study. Clin Transplant. 2024 Feb;38(2):e15259. doi: 10.1111/ctr.15259. PMID: 38375952.
  8. Im GY, Goel A, Asrani S, Singal AK, Wall A, Sherman CB. Transplant selection simulation: Liver transplantation for alcohol-associated hepatitis. Liver Transpl. 2023 Nov 28.
  9. Hernaez R, Karvellas CJ, Liu Y, Sacleux SC, Khemichian S, Stein LL, Shetty K, Lindenmeyer CC, Boike JR, Simonetto DA, Rahimi RS, Jalal PK, Izzy M, Kriss MS, Im GY, Lin MV, Jou JH, Fortune BE, Cholankeril G, Kuo A, Mahmud N, Kanwal F, Saliba F, Sundaram V, Artzner T, Jalan R. The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure. J Hepatol. 2023 Sep;79(3):717-727. Contribution: study design, data collection, manuscript revision
  10. Tholey DM, Lopatin S, Roth N, Im GY. What’s in a name? Higher risks with donation after cardiac death than public health service increased risk livers. Journal of Liver Transplantation. 2023 Feb;9:1-8.
  11. Hsu CC, Dodge JL, Weinberg E, Im GY, Ko J, Davis W, Rutledge S, Dukewich M, Shoreibah M, Aryan M, Vosooghi A, Lucey M, Rice J, Terrault NA, Lee BP. Multi-Centered study of patient outcomes after declined for early liver transplantation in severe Alcohol-associated hepatitis. Hepatology. Apr 1;77(4):1253-1262. Contribution: study design, data collection, manuscript revision
  12. Weinberg EM, Dukewich M, Jakhete N, Stonesifer E, Im GY, Lucey MR, Shetty K, Rice JP, Victor DW 3rd, Ghobrial MR, Shetty A, Rutledge SM, Florman SS, Hsu C, Shoreibah M, Aryan M, Orandi BJ, Han H, Terrault N, Lee BP. Early Liver Transplantation for Severe Alcohol-Associated Hepatitis and a History of Prior Liver Decompensation. Am J Gastroenterol. 2022 Dec 1;117(12):1990-1998. Contribution: study design, data collection, manuscript revision
  13. Dienstag A, Dienstag P, Mohan K, Mirza O, Schubert E, Ford L, Edelman M, Im GY, Shenoy A. An Assessment of the Psychosocial Evaluation for Early Liver Transplantation in Patients With Acute Alcoholic Hepatitis in the Context of Alcohol Use Disorder, a Case-Control Study. Subst Abuse. 2022 Aug 10;16:11782218221115659. doi: 10.1177/11782218221115659. PMID: 35966615; PMCID: PMC9373124. Contribution: study design, data collection, manuscript revision
  14. Lee BP, Roth N, Rao P, Im GY, Vogel AS, Hasbun J, Roth Y, Shenoy A, Arvelakis A, Ford L, Dawe I, Schiano TD, Davis JP, Rice JP, Eswaran S, Weinberg E, Han H, Hsu C, Fix OK, Maddur H, Ghobrial RM, Therapondos G, Dilkina B, Terrault NA. Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis. Am J Transplant. 2022 Jul;22(7):1834-1841. doi: 10.1111/ajt.17059. Epub 2022 Apr 25. PMID: 35416409; PMCID: PMC9541176. Contribution: study design, data collection, manuscript revision
  15. Cotter TG, Odenwald MA, Lieber SR, Rich NE, Im GY, Charlton M, Singal AG, Mitchell MC. The Practice of Retransplantation for Recurrent Alcohol-associated Liver Disease in the United States Is Uncommon With Acceptable Outcomes. Transplant Direct. 2022 Feb 11;8(3):e1297. doi: 10.1097/TXD.0000000000001297. PMID: 35187219; PMCID: PMC8843372. Contribution: study design, manuscript revision
  16. †Lee BP, Im GY, Rice JP, Lazar A, Weinberg E, Han H, Maddur H, Ghobrial RM, Therapondos G, Hsu C, Fix OK, Eswaran S, Shetty K, Chhatwal J, Dalgic OO, Jakhete N, Mobley C, Victor DW, Mehta N, Dinges L, Rinella M, Schiano TD, Lucey MR, Terrault N. Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis. Clin Gastroenterol Hepatol. 2022 Feb;20(2):409-418.e5. doi: 10.1016/j.cgh.2020.11.024. Epub 2020 Dec 3. PMID: 33279780.
  17. †Im GY, Vogel AS, Florman S, Nahas J, Friedman SL, Aqui S, Ford L, Mirza O, Kim-Schluger L, Schiano TD. Extensive Health Care Utilization and Costs of an Early Liver Transplantation Program for Alcoholic Hepatitis. Liver Transpl. 2022 Jan;28(1):27-38. doi: 10.1002/lt.26215. Epub 2021 Aug 7. PMID: 34133847.
  18. Im GY, Mellinger JL, Winters A, Aby ES, Lominadze Z, Rice J, Lucey MR, Arab JP, Goel A, Jophlin LL, Sherman CB, Parker R, Chen PH, Devuni D, Sidhu S, Dunn W, Szabo G, Singal AK, Shah VH. Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients With Liver Disease: A Survey From the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group. Clin Gastroenterol Hepatol. 2021 Nov;19(11):2407-2416.e8. doi: 10.1016/j.cgh.2020.10.026. Epub 2020 Oct 16. PMID: 33069880; PMCID: PMC8291372.
  19. Crismale JF, Huisman T, Deshpande R, Law C, Im GY, Bronster D, DeMaria S Jr, Florman S, Schiano TD. A protocol for the management of hyponatremia peri-liver transplant reduces post-transplant neurological complications. Clin Transplant. 2021 May;35(5):e14276. doi: 10.1111/ctr.14276. Epub 2021 Mar 23. PMID: 33675554. Contribution: data collection, manuscript revision
  20. *Rutledge SM, Schiano TD, Florman S, Im GY.?COVID-19 Aftershocks on Alcohol-associated Liver Disease: An Early Cross-Sectional Report from the U.S. Epicenter.?Hepatol Commun.?2021 Jul;5(7):1151-1155.
  21. Jones JM, Kracalik I, Rana MM, Nguyen A, Keller BC, Mishkin A, Hoopes C, Kaleekal T, Humar A, Vilaro J, Im GY, Smith L, Justice A, Leaumont C, Lindstrom S, Whitaker B, La Hoz RM, Michaels MG, Klassen D, Kuhnert W, Basavaraju SV.?SARS-CoV-2 Infections among Recent Organ Recipients, March-May 2020, United States.?Emerg Infect Dis.?2021 Feb;27(2):552-555. Contribution: data collection, manuscript revision
  22. Da BL, Im GY, Schiano TD. Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease. Hepatology. 2020 Sep;72(3):1102-1108. doi: 10.1002/hep.31307. PMID: 32369624. Contribution: manuscript writing and revision
  23. Lee BT, Perumalswami PV, Im GY, Florman S, Schiano TD; COBE Study Group. COVID-19 in Liver Transplant Recipients: An Initial Experience From the US Epicenter. Gastroenterology. 2020 Sep;159(3):1176-1178.e2. doi: 10.1053/j.gastro.2020.05.050. Epub 2020 May 20. PMID: 32442561; PMCID: PMC7237372. Contribution: data collection, manuscript writing and revision
  24. Lee BP, Im GY, Rice JP, Weinberg E, Hsu C, Fix OK, Therapondos G, Han H, Victor DW, Eswaran S, Maddur H, Terrault NA. Underestimation of Liver Transplantation for Alcoholic Hepatitis in the National Transplant Database. Liver Transpl. 2019 May;25(5):706-711. doi: 10.1002/lt.25448. Epub 2019 Mar 29. PMID: 30882995; PMCID: PMC6508584.
  25. Lee BP, Samur S, Dalgic OO, Bethea ED, Lucey MR, Weinberg E, Hsu C, Rinella ME, Im GY, Fix OK, Therapondos G, Han H, Victor DW, Voigt MD, Eswaran S, Terrault NA, Chhatwal J. Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis. Gastroenterology. 2019 Aug;157(2):472-480.e5. doi: 10.1053/j.gastro.2019.04.012. Epub 2019 Apr 15. PMID: 30998988; PMCID: PMC6650344. Contribution: data collection, manuscript writing and revision
  26. Parker R, Kim SJ, Im GY, Nahas J, Dhesi B, Vergis N, Sinha A, Ghezzi A, Rink MR, McCune A, Aithal GP, Newsome PN, Weston CJ, Holt A, Gao B. Obesity in acute alcoholic hepatitis increases morbidity and mortality. EBioMedicine. 2019 Jul;45:511-518. doi: 10.1016/j.ebiom.2019.03.046. Epub 2019 Jul 3. PMID: 31278069; PMCID: PMC6642069. Contribution: study design, data collection, manuscript writing and revision
  27. Lee BP, Vittinghoff E, Hsu C, Han H, Therapondos G, Fix OK, Victor DW, Dronamraju D, Im GY, Voigt MD, Rice JP, Lucey MR, Eswaran S, Chen PH, Li Z, Maddur H, Terrault NA. Predicting Low Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The Sustained Alcohol Use Post-Liver Transplant Score. Hepatology. 2019 Apr;69(4):1477-1487. doi: 10.1002/hep.30478. Epub 2019 Mar 5. PMID: 30561766; PMCID: PMC6453818. Contribution: data collection, manuscript writing and revision
  28. Lee BP, Mehta N, Platt L, Gurakar A, Rice JP, Lucey MR, Im GY, Therapondos G, Han H, Victor DW, Fix OK, Dinges L, Dronamraju D, Hsu C, Voigt MD, Rinella ME, Maddur H, Eswaran S, Hause J, Foley D, Ghobrial RM, Dodge JL, Li Z, Terrault NA. Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis. Gastroenterology. 2018 Aug;155(2):422-430.e1. doi: 10.1053/j.gastro.2018.04.009. Epub 2018 Apr 12. PMID: 29655837; PMCID: PMC6460480. Contribution: study design, data collection, manuscript writing and revision
  29. Trépo E, Goossens N, Fujiwara N, Song WM, Colaprico A, Marot A, Spahr L, Demetter P, Sempoux C, Im GY, Saldarriaga J, Gustot T, Devière J, Thung SN, Minsart C, Sersté T, Bontempi G, Abdelrahman K, Henrion J, Degré D, Lucidi V, Rubbia-Brandt L, Nair VD, Moreno C, Deltenre P, Hoshida Y, Franchimont D. Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis. Gastroenterology. 2018 Mar;154(4):965-975. doi: 10.1053/j.gastro.2017.10.048. Epub 2017 Nov 20. PMID: 29158192; PMCID: PMC5847453. Contribution: study design, data collection, manuscript writing and revision
  30. Bichoupan K, Tandon N, Crismale JF, Hartman J, Del Bello D, Patel N, Chekuri S, Harty A, Ng M, Sigel KM, Bansal MB, Grewal P, Chang CY, Leong J, Im GY, Liu LU, Odin JA, Bach N, Friedman SL, Schiano TD, Perumalswami PV, Dieterich DT, Branch AD. Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results. World J Virol. 2017 Nov 12;6(4):59-72. doi: 10.5501/wjv.v6.i4.59. PMID: 29147645; PMCID: PMC5680347. Contribution: data collection
  31. Parker R, Im GY, Jones F, Hernández OP, Nahas J, Kumar A, Wheatley D, Sinha A, Gonzalez-Reimers E, Sanchez-Pérez M, Ghezzi A, David MD, Corbett C, McCune A, Aithal GP, Holt A, Stewart S. Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort study. J Gastroenterol. 2017 Nov;52(11):1192-1200. doi: 10.1007/s00535-017-1336-z. Epub 2017 Apr 7. PMID: 28389732; PMCID: PMC5666044. Contribution: study design, data collection, manuscript writing and revision
  32. *Goel A, Biewald M, Huprikar S, Schiano T, Im GY. A Real-World Evaluation of Repeat Paracentesis-guided Management of Spontaneous Bacterial Peritonitis. J Clin Gastroenterol. 2017 Mar;51(3):278-284. doi: 10.1097/MCG.0000000000000704. PMID: 27661968. Contribution: study design, data collection and analysis, manuscript writing and revision
  33. Patel N, Bichoupan K, Ku L, Yalamanchili R, Harty A, Gardenier D, Ng M, Motamed D, Khaitova V, Bach N, Chang C, Grewal P, Bansal M, Agarwal R, Liu L, Im G, Leong J, Kim-Schluger L, Odin J, Ahmad J, Friedman S, Dieterich D, Schiano T, Perumalswami P, Branch A. Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus. World J Gastroenterol. 2016 Mar 7;22(9):2844-54. doi: 10.3748/wjg.v22.i9.2844. PMID: 26973423; PMCID: PMC4778007. Contribution: data collection, manuscript revision
  34. Im GY, Kim-Schluger L, Shenoy A, Schubert E, Goel A, Friedman SL, Florman S, Schiano TD. Early Liver Transplantation for Severe Alcoholic Hepatitis in the United States--A Single-Center Experience. Am J Transplant. 2016 Mar;16(3):841-9. doi: 10.1111/ajt.13586. Epub 2015 Dec 28. PMID: 26710309. Contribution: study design, data collection and analysis, manuscript writing
  35. †Stavropoulos SN, Im GY, Jlayer Z, Harris MD, Pitea TC, Turi GK, Malet PF, Friedel DF, Grendell JH. High Yield of Same Session EUS-guided Liver Biopsy by 19-gauge FNA Needle in Patients Undergoing EUS to Exclude Biliary Obstruction. Gastrointestinal Endoscopy 2012 Feb;75(2):310-318.
  36. Im GY, Modayil R, Katz D, Lin CT, Geier SJ, Grendell JH. The Appendix May Be Protective Against Clostridium difficile Recurrence. Clinical Gastroenterology and Hepatology 2011 Dec;9(12):1072-1077. Cover article.
  37. Brahmania M, Kuo A, Tapper EB, Volk M, Vittorio JM, Ghabril M, Morgan T, Kanwal F, Parikh ND, Martin P, Mehta S, Winder GS, Im GY, Goldberg D, Lai JC, Duarte-Rojo A, Paredes AH, Patel AA, Sahota A, McElroy LM, Thomas C, Wall AE, Malinis M, Aslam S, Simonetto DA, Ufere NN, Ramakrishnan S, Flynn MM, Ibrahim Y, Asrani SK, Serper M. Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2024 Mar 27. Contribution: Data analysis, manuscript revision
  38. Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology. 2020 Jan;71(1):306-333. doi: 10.1002/hep.30866. PMID: 31314133. Contribution: Data analysis, manuscript revision
  39. Asrani SK, Trotter J, Lake J, Ahmed A, Bonagura A, Cameron A, DiMartini A, Gonzalez S, Im GY, Martin P, Mathurin P, Mellinger J, Rice JP, Shah VH, Terrault N, Wall A, Winder S, Klintmalm G. Meeting Report: The Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis. Liver Transpl. 2020 Jan;26(1):127-140. doi: 10.1002/lt.25681. PMID: 31743578; PMCID: PMC8151800. Contribution: Data analysis, manuscript revision
  40. Lucey MR, Im GY, Mellinger JL, Szabo G, Crabb DW. Introducing the 2019 American Association for the Study of Liver Diseases Guidance on Alcohol-Associated Liver Disease. Liver Transpl. 2020 Jan;26(1):14-16. doi: 10.1002/lt.25600. Epub 2019 Aug 21. PMID: 31299131. Contribution: manuscript revision
  41. Im GY, Cameron AM, Lucey MR. Liver transplantation for alcoholic hepatitis. J Hepatol. 2019 Feb;70(2):328-334. doi: 10.1016/j.jhep.2018.11.007. PMID: 30658734.
  42. Im GY. Second thoughts about second opinions for liver transplantation. Liver Transpl. 2023 Dec 1;29(12):1253-1254. doi: 10.1097/LVT.0000000000000262. Epub 2023 Sep 26. PMID: 37747274.
  43. Im GY. Emerging Biomarkers in Alcohol-associated Hepatitis. J Clin Exp Hepatol. 2023 Jan-Feb;13(1):103-115. doi: 10.1016/j.jceh.2022.07.246. Epub 2022 Aug 1. PMID: 36647419; PMCID: PMC9840081.
  44. *Winters AC, Aby ES, Fix OK, German M, Haque LYK, Im GY. Joining the Fight: Enhancing Alcohol Treatment Education in Hepatology. Clin Liver Dis (Hoboken). 2021 Nov 20;18(5):225-229. doi: 10.1002/cld.1127. PMID: 34840723; PMCID: PMC8605691.
  45. *Shenoy A, Dienstag A, Dienstag P, Ford L, Schubert E, Wankoff M, Mohan K, Mirza O, Bhardwaj M, Im GY. Scoring systems to assess relapse risk in alcohol use disorder presenting for early liver transplantation: A systematic review. Gen Hosp Psychiatry. 2021 Sep-Oct;72:23-30. doi: 10.1016/j.genhosppsych.2021.06.012. Epub 2021 Jun 28. PMID: 34229280.
  46. Rutledge SM, Im GY. Current and Future Biomarkers in Alcoholic Hepatitis. Clin Liver Dis. 2021 Aug;25(3):493-516. doi: 10.1016/j.cld.2021.03.010. Epub 2021 May 27. PMID: 34229836.
  47. Im GY, Neuberger J. Debate on Selection Criteria for Liver Transplantation for Alcoholic Hepatitis: Tighten or Loosen? Liver Transpl. 2020 Jul;26(7):916-921. doi: 10.1002/lt.25783. PMID: 32614520.
  48. Im GY. Outcomes of Liver Transplantation for Severe Alcohol-Related Hepatitis. Clin Liver Dis (Hoboken). 2019 May 31;13(5):123-127. doi: 10.1002/cld.795. PMID: 31236258; PMCID: PMC6544417.
  49. Im GY Overcoming Alcohol Addiction in Patients with Alcohol-Related Liver Disease. Curr Hepatology Rep 18, 73–80 (2019). https://doi.org/10.1007/s11901-019-00451-7
  50. Im GY. Acute Alcoholic Hepatitis. Clin Liver Dis. 2019 Feb;23(1):81-98. doi: 10.1016/j.cld.2018.09.005. Epub 2018 Oct 26. PMID: 30454835.
  51. Im GY. Primed for the spotlight: Transplantation for alcohol-associated liver disease. J Hepatol. 2018 Jul;69(1):253-254. doi: 10.1016/j.jhep.2018.03.014. Epub 2018 Apr 5. PMID: 29627224.
  52. Nahas J, Im GY. Early liver transplantation for severe alcoholic hepatitis. Clin Liver Dis (Hoboken). 2018 Apr 6;11(3):69-72. doi: 10.1002/cld.693. PMID: 30992792; PMCID: PMC6385942.
  53. Im GY, Lucey M. Practical Concerns and Controversies in Severe Alcoholic Hepatitis. Gastroenterol Hepatol (N Y) 2016 Aug;12(8):478-489.
  54. Im GY, Lubezky N, Facciuto ME, Schiano TD. Surgery in Patients with Portal Hypertension – a Pre-operative Checklist and Strategies for Attenuating Risk. Clinics in Liver Disease 2014 May;18(2):477-505.
  55. *Leong J, Im GY. Alcoholic Liver Disease: Evaluation and Selection of Candidates for Liver Transplantation. Clinics in Liver Disease. 2012 Nov;16(4):851-863.
  56. Im GY, Dieterich DT. Direct-Acting Antiviral Agents in patients with Hepatitis C Cirrhosis. Gastroenterol Hepatol (N Y) 2012 Nov;8(11):727-765. Cover article.
  57. Ono A, Goossens N, Finn RS, Schmidt WN, Thung SN, Im GY, Hoshida Y; Precision Liver Cancer Prevention Consortium. Persisting risk of hepatocellular carcinoma after hepatitis C virus cure monitored by a liver transcriptome signature. Hepatology. 2017 Oct;66(4):1344-1346. doi: 10.1002/hep.29203. Epub 2017 Aug 26. PMID: 28390144; PMCID: PMC5605396.
  58. *Glass JP, Im GY. DIC in decompensated cirrhosis caused by prothrombin complex concentrate and recombinant activated factor VII: A word of caution. Liver Int. 2017 Sep;37(9):1412-1413. doi: 10.1111/liv.13493. Epub 2017 Jul 5. PMID: 28609569.
  59. Im GY, Ward S, Sehgal V. A Case of Undulating Fevers and Elevated Liver Tests After Pancreas-Kidney Transplantation. Seminars in Liver Diseases 2013 Feb;33(1):89-93.
  60. Im GY, Schrope BA, Stavropoulos SN. An Unusual Case of Pancreatitis. Gastroenterology 2011 Dec;141(6):e9-e10.
  61. Im GY, Kazi S, Thung SN, Perumalswami P. A maxed-out liver: a case of acute on chronic liver failure. Seminars in Liver Diseases 2011 Nov;31(4):420-426.